Navigation Links
HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid-Beta Accumulation, a Hallmark of Alzheimer's Disease
Date:9/3/2009

earch, three standardized turmeric extracts were prepared that were enriched in curcuminoids and turmerones, two major classes of compounds present in turmeric. Each of the three proprietary extracts had a different chemical profile and was standardized using advanced extraction technology developed by HerbalScience to create herbal extracts that are dose-reliable and efficacious. The activities of the extracts were compared to standard curcuminoids.

Inhibition of amyloid aggregation and secretion was studied in vitro among the different extracts and standards, and it was found that one of the extracts had the greatest activity in inhibiting the aggregation and secretion of amyloid. This extract, containing the highest levels of curcuminoids among all of the extracts, demonstrated activity that was significantly greater than curcumin alone, the most active of the four curcuminoid standards. This result indicates that an enriched turmeric extract could be just as or more effective than curcumin, the most commonly studied turmeric material for Alzheimer's disease.

The HerbalScience study also used advanced DART (Direct Analysis in Real Time) Time-of-Flight mass spectrometry technology to generate detailed chemical profiles of each extract in order to determine the key bioactive compounds. Only 5% of the compounds were known chemicals, with the remaining 95% being identified for the first time. With further chemical analysis and identification of key bioactives, highly standardized extracts such as these could offer a rich new source for potential drug discovery for Alzheimer's and other therapeutic targets.

The journal article detailing the study will appear in the December 2009 issue of Current Alzheimer's Research (Vol. 6, No. 6). Authors are R. Douglas Shytle, Paula C. Bickford, Kavon Rezai-zadeh, L Hou, Jin Zeng, Jun Tan, and Paul Sanberg, with University of South Florida College of Medicine affiliat
'/>"/>

SOURCE HerbalScience Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. HerbalScience Research Identifies Key Bioactives in Nettle Extract That Inhibit Inflammation Associated with Seasonal Allergies
2. HerbalScience Research Identifies Specific Bioactives In Stabilized Rice Bran Extract that Impart Anti-Inflammatory Benefits
3. NutraCea Forms Joint Ventures With HerbalScience to Develop Nutraceutical Extracts and Pharmaceutical Chemistries From Stabilized Rice Bran
4. Sensory Research Center Benefit Concert Yields Scholarships for Autistic Children
5. Fox Chase Cancer Center receives $8 million NIH grant to expand laboratory animal research facility
6. University of Georgia researchers show component of mothballs is present in deep-space clouds
7. Biomedical Research Centre developing enhanced cells as therapies
8. Video: Physical and Mental Health of U.S. Warfighter Is Focus of Military Health Research Forum
9. Researchers link inflammatory diseases to increased cardiovascular risk
10. AMR Research Analyst Named One of the Most Inspiring Individuals in Life Sciences by PharmaVOICE
11. Research Supports Improving Scoring of Costs and Benefits of Preventive Health Care to Better Inform Federal Budgetary Decisions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... A new study provides welcome news for patients ... (VTE). , The condition is estimated to impact ... when an abnormal clot forms in a vein and ... In some cases, the clot may detach from its ... the lungs, causing a potentially fatal condition known as ...
(Date:12/6/2009)... and members of the community, in cooperation with the Greater VA ... holiday party. This year,s attendance is expected to soar to more ... , ... (PRWEB) December 6, 2009 -- Volunteer organizations ... Healthcare System in West Los Angeles, will once again create a ...
(Date:12/5/2009)... a phase 1/2 clinical trial that it is ... newly diagnosed with multiple myeloma, a cancer of white ... Cancer Institute. , Partial responses or better were seen ... drug combination in the multi-center study, with 74 percent ... phase 2 population, reports Paul G. Richardson, MD, of ...
(Date:12/5/2009)... Dec. 5 ,, What: Cuts for ... difference in the fight against cancer and other terminal illnesses ... be donated to St. Jude Children,s Research Hospital. Guests will ... a delectable and savory Vietnamese restaurant in Falls Church for ...
(Date:12/5/2009)... Is Most Challenging-- ,, PHILADELPHIA and NEW ... genes, dubbed partner genes, that fuse with another gene ... By more accurately defining specific partner genes, researchers expect ... treatments. ,, Oncologists also aim to use this ...
Breaking Medicine News(10 mins):Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4
... melanoma when diagnosed by a dermatologist has a higher survival ... specialist will be able to detect// the tumor in its ... of survival. ,Individuals whose melanoma is diagnosed by ... and to survive five years than those with melanoma diagnosed ...
... from the researchers from Yale School of Medicine and ... first time found evidence of a// molecular mechanism that ... ,This discovery may help the development of ... and for cognitive changes in schizophrenia, bipolar disorder, or ...
... It may be an embattled country, what with Israel, Hizbollah ... ,But the thirst to look 'more beautiful' seems to remain ... National Bank has come forward to offer easy loans for ... surgery loans' as a way to 'have the life you've ...
... found that the use of remote monitoring for ... to significantly// improve clinical outcomes (mortality, morbidity and ... monitoring (telephone support or telemonitoring) to electronically transfer ... weight and ECG and oxygen details, to their ...
... seniors and others with Medicare to make the most of ... of Health and Human Services (HHS) and the Centers for ... Healthier US Starts Here. , It ... Medicare Prevention tour bus will visit each of the 48 ...
... of delivering drugs to fight cancers - by transporting ... be less// physically traumatic to patients, the team said ... of Singapore's department of chemical and biomolecular engineering believe ... under a standard microscope, are the delivery key. ...
Other Medicine News:Health News:Chances of Survival for Melanoma is High When Detected by Dermatologists 2Health News:New Light on Working of Brain Networks 2Health News:New Light on Working of Brain Networks 3Health News:Loans for Cosmetic Surgery in Lebanon 2Health News:Research Uncovers the Significant Benefits of Remote Monitoring 2Health News:Seniors Encouraged To Make Use Of Medicare’s Freebie 2
(Date:12/4/2009)... Dec. 4 Shared Imaging, LLC, an independent ... service programs for hospitals and healthcare providers, is ... Commission,s Accreditation for Ambulatory Health Care, a nationally-recognized, ... safety in patient care. Shared Imaging accreditation is ...
(Date:12/4/2009)... 4 PharmAthene, Inc. (NYSE Amex: PIP ... biological and chemical threats, announced today that the ... the effectiveness of Valortim® in an inhalation anthrax ... The data are being presented during an ...
(Date:12/4/2009)... today announced the three grand prize winners of Bayer,s "Express ... Brothers, selected the winning video entries submitted by children with ... in-person meeting today with Nick. ,, The winners, ... 6, from Danbury, CT, who dreams of becoming a major ...
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3AIAA names top ten emerging aerospace technologies of 2009 12399 1AIAA names top ten emerging aerospace technologies of 2009 12399 2Satellite Healthcare Steps Out in San Jose 47560 1Satellite Healthcare Steps Out in San Jose 47560 2BD to Present at Investor Healthcare Conferences 12398 1
... Astellas Pharma US, Inc. today,announced data ... serum sodium concentration ([Na+]) and is,well-tolerated among ... potentially life-threatening condition that occurs when the,body,s ... and safety profile of,VAPRISOL was comparable under ...
... DOYLESTOWN, Penn., Oct. 25 The Quigley,Corporation (Nasdaq: ... for,the third quarter ended September 30, 2007, compared to ... the nine-months ended September,30, 2007, net sales were $25.9 ... in 2006. The third quarter and first nine ...
Other Medicine Technology:Study Shows VAPRISOL(R) is Effective in Increasing Serum Sodium Levels and Well-Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia 2Study Shows VAPRISOL(R) is Effective in Increasing Serum Sodium Levels and Well-Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia 3Study Shows VAPRISOL(R) is Effective in Increasing Serum Sodium Levels and Well-Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia 4Study Shows VAPRISOL(R) is Effective in Increasing Serum Sodium Levels and Well-Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia 5The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy 2The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy 3The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy 4The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy 5The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy 6The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy 7
The Express Plus clinical chemistry analyzer is a fully automated walk away system designed for maximum productivity, convenience and reliability....
Seamlessly integrates with the i2000SR to form a state-of-the-art immunochemistry platform, the ci8200. Flexibility to prioritize STAT, automated rerun/dilution, and reflex testing over routines to e...
... and controls interchangeable with other Roche/Hitachi ... training costs. Consistent patient results throughout ... handling. 70 positions for routine, STAT ... volumes. Intermix sample types. Intermix 5 ...
Modular Pre-Analytics is an integral component of the new modular systems platform which combines pre-analytics, clinical chemistry and immunochemistry....
Medicine Products: